The effect of physiotherapy on development, extent and duration of motor problems in children with acute lymphoblastic leukaemia

Completed

• Conditions: Acute lymphoblastic leukaemia (ALL); Acute lymphoblastic leukaemia; Cancer

• Registration Number: ISRCTN63483122
• Lead Sponsor: Erasmus Medical Centre (Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-12-20
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 52

Inclusion Criteria

Children aged 1 - 18 years diagnosed with acute lymphoblastic leukaemia

Exclusion Criteria

1. Additional medical conditions known to have an effect on motor development
2. Cognitive impairment

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Motor performance is measured with the Motor Assessment Battery for Children - a standardised test for motor performance - at the onset of chemotherapy, after six weeks, one year after starting chemotherapy and on completion of therapy.

Secondary Outcome Measures

Name	Time	Method
Objective signs of polyneuropathy, i.e. decreased reflexes, sensory disturbance and muscle weakness are assessed.